Pittsburgh, PA, United States of America

Peter Wipf

This inventor holds 85 USPTO granted patents and 23 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Cancer Therapeutics (CPC class A61K45-06). Top assignees: University of Pittsburgh, The United States of America, as Represented by the Secretary, Department of Health and Human Services, The University of Arizona. Active years: 1997-2026.

USPTO Granted Patents = 85 (Patent Applications = 23)

% Patents Active = 87.1

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 268(Granted Patents)

Forward Citations (Not Self Cited) = 155(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Pittsburg, PA (US) (2012)
Pittsburgh, PA (US) (1997 - 2023)

Company Filing History:

84 out of 1,955

University of Pittsburgh

patents

4 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

4 out of 1,045

The University of Arizona

patents

4. 3 out of 15,964

University of California

patents

5. 3 out of 1,036

University of Virginia Patent Foundation

patents

6. 2 out of 2,146

Arizona State University

patents

7. 2 out of 3,790

Johns Hopkins University

patents

8. 2 out of 178

Musc Foundation for Research Development

patents

9. 2 out of 6

Prolx Pharmaceuticals Corporation

patents

10. 1 out of 1

Proix Pharmaceutical Corp.

The Brigham and Women's Hospital, Inc.

patents

where one patent can have more than one assignee

Years Active: 1997-2026

Loading Chart...

Areas of Expertise:

P97 ATPase Inhibitors

Prostate Cancer Treatments

Mitochondrial PARP Inhibitors

Nitroxide Compounds

Calcium Channel Agonists

TLR4 Inhibitors

Inhibitors of STAT3

Phenyl Indole Inhibitors

Organic Acidemias

Ferroptosis-related Diseases

Anti-inflammatory Agents

Bone Healing Compounds

85 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12600705 - Heat shock protein modulators and anti-Huntington disease therapeutic agents (2026-04-14),

2. 12559480 - Methods of treatment using phenyl indole allosteric inhibitors of P97 ATPase (2026-02-24),

3. 12486231 - Targeted nitroxide compounds and their use in treating ferroptosis-related diseases (2025-12-02),

4. 12227515 - In-flow photooxygenation of aminothienopyridinones generates novel PTP4A3 phosphatase inhibitors (2025-02-18),

5. 12202839 - In-flow photooxygenation of aminothienopyridinones generates PTP4A3 phosphatase inhibitors (2025-01-21),

6. 12202811 - Compounds for treating prostate cancer (2025-01-21),

7. 12128038 - Method of treatment of organic acidemias and other mitochondria defects or deficiencies (2024-10-29),

8. 11773075 - Modulators of p97 AAA ATPase activity (2023-10-03),

9. 11766433 - Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer (2023-09-26),

10. 11759524 - Mitochondrially targeted PARP inhibitor, and uses thereof (2023-09-19),

11. 11718600 - 1,2,3-triazole inhibitors of P97 AAA ATPase activity (2023-08-08),

12. 11413299 - Compositions and methods for treatment of inflammatory disorders (2022-08-16),

13. 11358930 - Selective potassium channel agonists (2022-06-14),

14. 11247985 - Phenyl indole allosteric inhibitors of P97 ATPase (2022-02-15),

15. 11214560 - Modulators of P97 AAA ATPase activity (2022-01-04),

Title: The Innovative Journey of Peter Wipf

Introduction: Peter Wipf, a distinguished inventor based in Pittsburgh, PA, has made significant contributions to the field of innovation with his groundbreaking work in various patents and inventions.

Latest Patents: Peter Wipf holds several patents in the areas of pharmaceuticals, organic chemistry, and materials science, showcasing his versatility and expertise in multiple domains of innovation.

Career Highlights: Throughout his illustrious career, Peter Wipf has been recognized for his pioneering research and inventive spirit, leading to the development of cutting-edge technologies that have revolutionized their respective industries.

Collaborations: Peter Wipf has collaborated with top research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge exchange that has propelled his inventions to new heights of success.

Conclusion: Peter Wipf's unwavering dedication to innovation, coupled with his exceptional talent and collaborative efforts, continues to inspire the next generation of inventors and researchers to push the boundaries of what is possible in the world of patents and inventions.